Concepedia

Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant

Thomas Frogne, Rikke Vicki Benjaminsen, Katrine Sonne‐Hansen, Boe Sandahl Sørensen, Anne‐Vibeke Lænkholm, Louise M. Rasmussen, David J. Riese, Patricia de Crémoux, Jan Stenvang, Anne E. Lykkesfeldt

Breast Cancer Research and Treatment · 2008 · 155 citations · 41 references

DOIFull text

Open access

Concepts

References

41

<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling

Jeffrey A. Engelman, Kreshnik Zejnullahu, Tetsuya Mitsudomi et al. · Science · 2007 · 4.5K citations · Full text

, , +17

Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3

Natalia Sergina, Megan Rausch, Donghui Wang et al. · Nature · 2007 · 989 citations · Full text

, , +14

Expression of the HER1–4 family of receptor tyrosine kinases in breast cancer

Caroline Witton, Jonathan R. Reeves, James J. Going et al. · The Journal of Pathology · 2003 · 592 citations

, , +14

Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer

Bin-Bing Zhou, Michael Peyton, Biao He et al. · Cancer Cell · 2006 · 375 citations · Full text

, , +11

Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer

Anthony Howell, D.J. DeFriend, R.W. Blamey et al. · The Lancet · 1995 · 349 citations

, , +15